scorecardresearch
Add as a preferred source on Google
Thursday, September 25, 2025
TopicInsulin

Topic: Insulin

Eli Lilly announces trial results for world’s 2nd weekly insulin, aims for launch by year-end

New Delhi: There is excitement and hope in the insulin market the world over after U.S. based pharma giant Eli Lilly & Company on...

Big pharma pivoting to more lucrative obesity segment, Indian drugmakers eye insulin market

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady entry into a market once dominated by Big pharma.

Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, received CDSCO approval this week.

Danish scientists create ‘smart’ insulin with ‘on-off’ switch to target blood sugar highs & lows

Novo Nordisk scientists have synthesised an insulin molecule that specifically targets glucose in blood, instead of other sugars like fructose, to aid treatment of all types of diabetes.

Ozempic makers could be raking in 40,000% profit — study says diabetes drug can be made for $1/month

Doctors Without Borders says new class of drugs & insulin devices could be leading to ‘exorbitant corporate profiteering’. Study published in Journal of the American Medical Association.

India denies nod to ‘1st-ever weekly insulin’ for diabetics, seeks more info from maker Novo Nordisk

Icodec has been touted as a therapy that could eliminate the need for daily or mealtime insulin injections for people with severe diabetes. It has not been approved by any country so far.

‘Diabetes capital’ India slated to get world’s 1st once-a-week insulin ‘by 2025’

Danish pharma giant Novo Nordisk's Icodec could be game-changer for diabetics. The drug is nearing regulatory approval in US & EU, says company.

Respite from daily pricks? Hopes high for diabetics as weekly insulin dose nears global approvals

Danish pharmaceutical giant Novo Nordisk has said it is set to apply for regulatory approval of its once-a-week insulin drug, Icodec. Results of Phase-3 clinical trial shown 'promising results'.

Artificial pancreas may soon be lifeline for UK’s type 1 diabetics. Why it’s not yet big in India

UK patients may soon be covered for the device, which measures blood glucose, computes amount of insulin needed and then pumps that exact amount into bloodstream.

Discovery of insulin was about monstrous egos and career rivalries. And of course, diabetes

We might think technological solutions do the heavy lifting. But they are effective only when accompanied by changes in behaviour.

On Camera

Theaterisation reform is stuck on ranks and roles — India’s military needs clarity

On paper, the idea of theaterisation is elegant. In practice, it is paralysed by ambiguities of rank and command.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

‘Agni’ on the move—India successfully test-fires Agni-Prime nuclear missile from a train

With the latest test, India has the capability to launch a nuclear missile from under the sea, surface, air, and now from a railway network.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.